1. Home
  2. ABM vs ADPT Comparison

ABM vs ADPT Comparison

Compare ABM & ADPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ABM Industries Incorporated

ABM

ABM Industries Incorporated

HOLD

Current Price

$38.76

Market Cap

2.6B

Sector

Finance

ML Signal

HOLD

Logo Adaptive Biotechnologies Corporation

ADPT

Adaptive Biotechnologies Corporation

HOLD

Current Price

$13.17

Market Cap

2.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ABM
ADPT
Founded
1909
2009
Country
United States
United States
Employees
N/A
N/A
Industry
Diversified Commercial Services
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.6B
2.5B
IPO Year
1994
2019

Fundamental Metrics

Financial Performance
Metric
ABM
ADPT
Price
$38.76
$13.17
Analyst Decision
Buy
Strong Buy
Analyst Count
5
9
Target Price
$47.80
$17.78
AVG Volume (30 Days)
453.0K
1.7M
Earning Date
06-09-2026
05-05-2026
Dividend Yield
3.00%
N/A
EPS Growth
102.34
63.89
EPS
0.64
N/A
Revenue
$8,745,900,000.00
$276,976,000.00
Revenue This Year
$5.71
$3.98
Revenue Next Year
$1.99
$22.72
P/E Ratio
$60.42
N/A
Revenue Growth
4.62
54.77
52 Week Low
$38.58
$6.68
52 Week High
$52.94
$20.76

Technical Indicators

Market Signals
Indicator
ABM
ADPT
Relative Strength Index (RSI) 26.44 30.42
Support Level N/A $12.32
Resistance Level $46.93 $13.45
Average True Range (ATR) 1.35 0.82
MACD -0.61 -0.29
Stochastic Oscillator 10.72 20.71

Price Performance

Historical Comparison
ABM
ADPT

About ABM ABM Industries Incorporated

ABM Industries Inc is a provider of integrated facility solutions. It offers its solutions through five segments: Business and Industry, Manufacturing and Distribution, Education, Aviation and Technical solutions. The company derives the majority of its revenue from the business and industry segment, which encompasses janitorial, facilities engineering, and parking services for commercial real estate properties and sports and entertainment venues, hospitals, as well as vehicle maintenance and other services to rental car providers. The company mainly operates in the United States of America.

About ADPT Adaptive Biotechnologies Corporation

Adaptive Biotechnologies Corp is a company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is test authorized by the FDA for the detection and monitoring of minimal residual disease (MRD) in patients with multiple myeloma (MM), B cell acute lymphoblastic leukemia (ALL) and chronic lymphocytic leukemia (CLL) and is also available as a CLIA-validated laboratory developed test (LDT) for patients with other lymphoid cancers, including diffuse large B-cell lymphoma (DLBCL).

Share on Social Networks: